If a company has some serious $$, why would they not try challenging the patents of A2MC if they have a different way of marketing it? They may not be able to use the same trademark, but surely they could say "This product contains only A2 protein and no A1 protein" which in itself is a scientific claim/explanation of the product? The likes of Fonterra and Pura or Nestle could easily do it, right?
If a company has some serious $$, why would they not try...
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.59 |
Change
-0.120(2.10%) |
Mkt cap ! $4.047B | |||
| Open | High | Low | Value | Volume |
| $5.70 | $5.71 | $5.56 | $12.05M | 2.148M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 483 | $5.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.61 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |